compound 18j [PMID: 35446588]   Click here for help

GtoPdb Ligand ID: 12987

Compound class: Synthetic organic
Comment: Compound 18j is a fourth generation EGFR inhibitor [1]. It was designed to overcome EGFRC797S mutation-mediated resistance to third-generation irreversible inhibitors such as osimertinib.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 10
Hydrogen bond donors 1
Rotatable bonds 3
Topological polar surface area 113.44
Molecular weight 626.17
XLogP 4.64
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCS(=O)(=O)N1C=C2C3=C1C=C(C=C3)OCCCCCCOC4=CC(=C(C)C=C4N5CCOCC5)NC6=NC=C(C2=N6)Cl
Isomeric SMILES CCS(=O)(=O)N1C=C2C3=C1C=C(OCCCCCCOC4=CC(NC5=NC2=C(Cl)C=N5)=C(C)C=C4N6CCOCC6)C=C3
InChI InChI=1S/C31H36ClN5O5S/c1-3-43(38,39)37-20-24-23-9-8-22(17-27(23)37)41-12-6-4-5-7-13-42-29-18-26(34-31-33-19-25(32)30(24)35-31)21(2)16-28(29)36-10-14-40-15-11-36/h8-9,16-20H,3-7,10-15H2,1-2H3,(H,33,34,35)
InChI Key SOZJLUNPQMFFFL-UHFFFAOYSA-N
References
1. Chen H, Lai M, Zhang T, Chen Y, Tong L, Zhu S, Zhou Y, Ren X, Ding J, Xie H et al.. (2022)
Conformational Constrained 4-(1-Sulfonyl-3-indol)yl-2-phenylaminopyrimidine Derivatives as New Fourth-Generation Epidermal Growth Factor Receptor Inhibitors Targeting T790M/C797S Mutations.
J Med Chem, 65 (9): 6840-6858. [PMID:35446588]